Colleen represents emerging high-growth companies throughout their life cycle, with a focus on all aspects of emerging company development, including corporate formation, venture capital financings, and mergers and acquisitions. She also has experience representing public companies and investment banks in public offerings and private placements of equity and debt securities. Colleen is counsel to companies and their investors in a broad range of industries, with a focus on technology and life sciences.

Download full bio 


  • General Catalyst Leads Eleanor Health’s $50 Million Series C  

  • Helion Energy Raises $2.2 Billion With Series E Round 

  • Avalara – $500 Million Follow-On Offering 

  • Redfin – $661.25 Million Convertible Senior Notes Offering 

  • J2 Global – $750 Million High-Yield Bond Offering 

  • View all


  • University of Michigan Law School
    JD, magna cum laude, 2014

  • Loyola Marymount University
    BA, Psychology
    magna cum laude, 2011

Admissions & Credentials